Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024.

Blincyto (blinatumomab) - Astellas, Amgen

vibecotamab (XmAb14045) - Xencor

Besponsa (inotuzumab ozogamicin) - Pfizer

AFM28 - Affimed

http://www.ncbi.nlm.nih.gov/pubmed/40270605

Hanzhou Xing; Jifeng Yu; Lijie Han; Shuhan Ma; Weijie Cao; Xuejun Guo; Yingmei Li; Zhongxing Jiang

Apr 27, 2025